Agonistic autoantibodies of the AT1 receptor (predominantly found in preeclampsia or malignant hypertension patients) modulate the AT1 receptor via ECL2, which is outside the orthosteric binding site of Ang II11. Here, AGTR1 is linked to malignant hypertension.